Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children
about
Update on the burden of Campylobacter in developing countries.Does EBV alter the pathogenesis of malaria?Reconstruction of Rift Valley fever transmission dynamics in Madagascar: estimation of force of infection from seroprevalence surveys using Bayesian modellingStrategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical modelThe Impact of Hotspot-Targeted Interventions on Malaria Transmission in Rachuonyo South District in the Western Kenyan Highlands: A Cluster-Randomized Controlled TrialInferring infection hazard in wildlife populations by linking data across individual and population scales.Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathwayFitness estimates from experimental infections predict the long-term strain structure of a vector-borne pathogen in the field.Synergistic effect of IL-12 and IL-18 induces TIM3 regulation of γδ T cell function and decreases the risk of clinical malaria in children living in Papua New GuineaNatural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments.Plasmodium falciparum infection patterns since birth and risk of severe malaria: a nested case-control study in children on the coast of Kenya.Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of responseA high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean children.Dynamics of the force of infection: insights from Echinococcus multilocularis infection in foxes.Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity.Uncovering the transmission dynamics of Plasmodium vivax using population geneticsNovel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communitiesAn Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection.Malaria Epidemiology and Control Within the International Centers of Excellence for Malaria ResearchMalaria Molecular Epidemiology: Lessons from the International Centers of Excellence for Malaria Research Network.Longitudinal analysis of Plasmodium falciparum genetic variation in Turbo, Colombia: implications for malaria control and eliminationMolecular incidence and clearance of Plasmodium falciparum infection.Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics.Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in UgandaMobile phones and malaria: modeling human and parasite travel.Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children.Critical Evaluation of Molecular Monitoring in Malaria Drug Efficacy Trials and Pitfalls of Length-Polymorphic Markers.Insights into the naturally acquired immune response to Plasmodium vivax malaria.The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New GuineaThe Incidence and Differential Seasonal Patterns of Plasmodium vivax Primary Infections and Relapses in a Cohort of Children in Papua New GuineaFocal Screening to Identify the Subpatent Parasite Reservoir in an Area of Low and Heterogeneous Transmission in the Kenya Highlands.Patterns of protective associations differ for antibodies to P.falciparum-infected erythrocytes and merozoites in immunity against malaria in children.Ivermectin: a complimentary weapon against the spread of malaria?Phylogeography of var gene repertoires reveals fine-scale geospatial clustering of Plasmodium falciparum populations in a highly endemic area.IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development.Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence
P2860
Q26861272-131D3727-C66F-4026-8503-45D4D4B4DFA8Q27022038-F1D4D9D3-2730-4D74-83B6-34DD9F2B605CQ28359552-DC6B18E6-505B-42CB-B2AC-B39B74218F19Q28550515-7889F1C1-90AD-4A4B-9C36-91645ABFD4A3Q28551321-455FF1CA-892C-434F-8268-07DCD41C1865Q31154831-BDE7B541-D5EA-4D1C-B7E1-00FAE917362DQ33593846-D043406B-35A5-476B-8AA7-CEFF7D904E21Q33686914-12FA40B1-91B0-499A-94B0-4653598030A0Q33802385-5E5A3E96-0959-48BF-AF03-E3D5986582FAQ33834779-63707C41-A7C1-49BA-9B7C-EBAB9D83D8DBQ34484629-F5B00452-D696-4051-B954-EED995F15F31Q34589755-73800B1A-6458-42D7-9BAD-87312AEC57CBQ34677891-355AA714-A686-465C-B3A1-C9CD7419C480Q34955461-61479F88-D320-4168-A3E2-7EDDCFDF4127Q34990680-160718DD-C2BB-43D5-9A35-AC49EA37A258Q35126544-52FED376-686E-42EA-80C9-1E6A591A95B7Q35628510-C74655A3-0F12-4E97-BDDB-3C4715D78ADDQ35682619-BB0186F5-A5DE-49C2-B104-481E0C704F18Q35961275-B5B93DD9-EA23-45F9-9642-ACD991BA1C74Q36018397-3A971D92-0509-4813-A977-81633977851AQ36071345-0F908BC3-0D1C-4DC0-B6A5-27C8515B8C8CQ36071351-5F72B113-D9F7-40B4-8E4C-D26ABA357F89Q36081955-EC7A0F3B-B24C-4C7F-90EE-D1DA0D965D22Q36202333-7870DC1B-3B1B-4FAE-A748-3D4B6AC88AFFQ36841992-58DE9E08-DA2D-474E-B4EA-7687E2A70D62Q36919292-0D7294CD-5FA6-4C9C-8CDD-045D1E53678DQ36969072-B7C9FBFB-B9DD-4127-9BEB-1622FB327F4DQ37247251-1502E085-B219-4D03-BCFC-550335217DF2Q37308698-BFD02307-0C91-494F-808C-34213F8CD22DQ37538733-E3C61F96-736B-48FA-B839-14EF034BF372Q38728598-65FD478B-2DEF-4B3F-8C28-77CC49E75EEBQ39071168-AC5E4453-4488-416B-B6D2-272050686F65Q39409632-A284DDCE-D97A-4572-AB74-3ECD1270A7ADQ39493802-EB9436B7-48EE-4E53-8C3F-77724FF5EF6FQ40073901-209801A5-A037-458C-8264-60DB29DFC1D7Q40411509-4C616DE3-3EE2-4935-B697-1EA8F1DE0579Q41613360-828D2A20-A564-4E60-B7A4-76191889AA55Q41956908-CA7B2498-87A4-4F6E-8D81-33187E680CCCQ41994105-C32F0200-C9BC-4297-AEB2-ABA9EF764C7AQ42127740-835074CD-D277-49E6-AAFB-2DE35AD3C13A
P2860
Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Force of infection is key to u ...... in Papua New Guinean children
@ast
Force of infection is key to u ...... in Papua New Guinean children
@en
type
label
Force of infection is key to u ...... in Papua New Guinean children
@ast
Force of infection is key to u ...... in Papua New Guinean children
@en
prefLabel
Force of infection is key to u ...... in Papua New Guinean children
@ast
Force of infection is key to u ...... in Papua New Guinean children
@en
P2093
P2860
P50
P921
P356
P1476
Force of infection is key to u ...... in Papua New Guinean children
@en
P2093
Benson Kiniboro
Kathryn L Benton
Michael T Bretscher
Sonja Schoepflin
P2860
P304
10030-10035
P356
10.1073/PNAS.1200841109
P407
P577
2012-06-04T00:00:00Z